cache/ed1e465497323ab1370d8262edf3e8a0f0bb9830345b5cf5e84a0b9f1bc6bd65

COM:AGOMAB

AgomAb

  • Privately Held

AgomAb is a biopharmaceutical company focused on the development of antibody-based therapies that modulate regenerative pathways to treat severe diseases.

peer of

investor of